Tetanus immunity among pregnant women attending antenatal care in Dar es Salaam, Tanzania.

This study was conducted to investigate immunity to tetanus among pregnant women with verbal histories or documentation of having been vaccinated under the current five-dose tetanus toxoid (TT) schedule. It examined sera from 176 pregnant women attending antenatal care at Muhimbili Medical Centre in Dar es Salaam, Tanzania. Tetanus antitoxin level of 0.1 IU/ml was considered protective. Our findings show that 94.9% of women had tetanus antitoxin > or = 0.1 IU/ml. Multivariate analysis revealed that time after last vaccination, TT doses received and TT vaccination status explained 7.5%, 5.7% and 2.3% of variations in tetanus antitoxin levels respectively. Pregnant women with non-protective levels of tetanus antitoxin (5.1%) pose great risks of neonatal tetanus to their newborns and are also susceptible to maternal tetanus. Proper keeping of TT vaccination records is vitally important to avoid hyper-immunisation.

[1]  K. Kjeldsen,et al.  The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology.

[2]  S. Aboud,et al.  Levels and avidity of antibodies to tetanus toxoid in children aged 1–15 years in Dar es Salaam and Bagamoyo, Tanzania , 2000, Annals of tropical paediatrics.

[3]  F. Cutts,et al.  Susceptibility to tetanus and missed vaccination opportunities in Portuguese women. , 1999, Vaccine.

[4]  K. Kjeldsen,et al.  Immunity to tetanus and diphtheria in rural Africa. , 1997, The American journal of tropical medicine and hygiene.

[5]  J. Thipphawong,et al.  Diphtheria and tetanus immunity among blood donors in Toronto. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[6]  R. Gilman,et al.  Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test. , 1993, American journal of public health.

[7]  V. Chongsuvivatwong,et al.  Control of neonatal tetanus in southern Thailand. , 1993, International journal of epidemiology.

[8]  G. Roy,et al.  Serological response to tetanus toxoid: a field study in Pondicherry, India. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  D. Bertsch,et al.  Impact of a tetanus toxoid immunization mass campaign on neonatal tetanus mortality in Aceh Province, Indonesia. , 1991, The Southeast Asian journal of tropical medicine and public health.

[10]  M. Huet,et al.  Antibody response of pregnant women to two different absorbed tetanus toxoids. , 1991, Vaccine.

[11]  J. Sokhey.  Elimination of neonatal tetanus: 1995. , 1991, The Journal of communicable diseases.

[12]  R. S. Rao,et al.  Serological survey of tetanus antibodies in the Pondicherry region. , 1988, The Indian journal of medical research.

[13]  N. T. Van,et al.  Tetanus antibodies measured by the toxin binding inhibition test (ToBI) in mothers and children in the Neonatal Tetanus Program in Vietnam. , 1999, Developments in biological standardization.

[14]  F. Gasse,et al.  The present status of tetanus and tetanus vaccination. , 1995, Current topics in microbiology and immunology.

[15]  F. Cutts,et al.  The use of evaluation to improve the Expanded Programme on Immunization in Mozambique. , 1990, Bulletin of the World Health Organization.